A Catalyst for Reform: Charting a Future for Orphan Drug Exclusivity
Forty years after the passage of the Orphan Drug Act, the Catalyst Pharmaceuticals v. Becerra decision has ignited debate over… Continue reading →
Forty years after the passage of the Orphan Drug Act, the Catalyst Pharmaceuticals v. Becerra decision has ignited debate over… Continue reading →